HAYWARD, Calif.--(BUSINESS WIRE)--March 11, 2008--IMPAX
Laboratories, Inc. (OTC:IPXL) today announced that Arthur A. Koch,
Jr., its senior vice president and chief financial officer, will
present at two upcoming investment conferences:
- IMPAX will present at the Cowen and Company 28th Annual Health
Care Conference on Monday, March 17th, at 2:30 p.m. Eastern
Time. The conference will be held at the Boston Marriott
Copley Place from March 17 to 20.
- The Company will also present at the Lehman Brothers Eleventh
Annual Global Healthcare Conference on Tuesday, March 18th, at
5:15 p.m. Eastern Time. The conference will be held at the
Loews Miami Beach Hotel from March 18 to 20.
Individuals may listen to the live or archived presentations made
at the conferences, which will be posted in the investor relations
section of the Company's web site at www.impaxlabs.com. To listen to
the live presentations, please go to the web site 15 minutes prior to
its start to register, download, and install the necessary audio
software. These presentations will be archived on the Company's web
site for 90 days.
About IMPAX Laboratories, Inc.
IMPAX Laboratories, Inc. is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded products.
IMPAX markets its generic products through its Global Pharmaceuticals
division and markets its branded products through the IMPAX
Pharmaceuticals division. Additionally, where strategically
appropriate, IMPAX has developed marketing partnerships to fully
leverage its technology platform. IMPAX Laboratories is headquartered
in Hayward, California, and has a full range of capabilities in its
Hayward and Philadelphia facilities. For more information, please
visit the Company's Web site at: www.impaxlabs.com.
CONTACT: Company Contacts:
IMPAX Laboratories, Inc.
Larry Hsu, Ph.D. President & CEO
510-476-2000, Ext. 1111
or
Arthur A. Koch, Jr., Sr. VP & CFO
215-933-0351
www.impaxlabs.com
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com
www.lhai.com
SOURCE: IMPAX Laboratories, Inc.